Alzheimer's Care Resources
« First | ‹ Previous |
AAIC® 2012 fuels international Alzheimer's research progress - AAIC drew more than 4,300 members of the Alzheimer's scientific community to Vancouver to share the latest ideas, thoughts and theories in the field. Breaking studies captured global media attention as the world's leading experts explored innovative ways to further Alzheimer's research. 07/20/2012
http://optimumseniorcare.com/blog/?p=629
http://www.alz.org/aaic/wed_130pmct_nia.asp
AAIC® 2012 fuels international Alzheimer's research progress -
Alzheimer's drug Bapineuzumab fails in Phase 3 clinical trial - Bapineuzumab, an experimental treatment for Alzheimer's disease, proved ineffective in a large-scale, late-stage clinical trial in people with Alzheimer's who carry a risk gene known as ApoE4. Researchers said the drug did not improve either cognition or daily functioning of study participants when compared to those who took a placebo. Additional Phase 3 clinical trials of the drug are expected to report results later this year. 07/25/2012
http://www.nytimes.com/2012/07/24/business/alzheimers-drug-fails-its-first-clinical-trial.html?_r=1
Can being an Alzheimer's caregiver make you happy? - Can being an Alzheimer's caregiver make you happy?
When it comes to caring for a loved one with Alzheimer's, happiness may not be the first emotion that comes to mind. But many of the activities associated with caregiving are principles that experts say make people happier.
Read the blog post>>
Visit our Caregiver Center >> 07/25/2012
http://blog.alz.org/can-caregiving-make-you-happy/
The Time is Now, Alzheimer's Can't Wait - Every year millions of Americans take to the streets to participate in local Walk to End Alzheimer's® events. In 2012, the Greater Illinois Chapter will host 17 Walks throughout our 68-county service area. Click here to register.
There are many varied reasons why people participate in Walk to End Alzheimer's. Many walk for a loved one who is facing Alzheimer's disease, some walk to remember and honor a loved one who has lost their battle with Alzheimer's, while others walk to help find a cure for the sixth leading cause of death in the United States. Here are five moving stories from walkers in the Greater Illinois Chapter about why they walk. 08/01/2012
http://www.alzheimers-illinois.org/enewsletter/august2012/walk.asp
Alzheimer's drug Bapineuzumab fails in second Phase 3 clinical trial - A second Phase 3 clinical trial of the drug bapineuzumab did not show benefits on tests of cognition and function in people with mild-to-moderate Alzheimer's disease. As a result, all ongoing studies with the drug, intended to break up beta amyloid protein plaques, will be discontinued. Although the results of bapineuzumab trial have been disappointing, setbacks provide critical information to the research community for application in future studies. 08/08/2012
http://abcnews.go.com/Health/AlzheimersNews/research-halted-major-alzheimers-drug/story?id=16946503
Walk To End Alzheimers - Alzheimers Association - The Alzheimers Association Walk to End Alzheimers is the nations largest event to raise awareness and funds for Alzheimers care, support and research. Held annually in more than 600 communities nationwide, this inspiring event calls on participants of all ages and abilities to reclaim the future for millions. Together, we can end Alzheimers disease, the nations sixth-leading cause of death. 08/10/2012
http://act.alz.org/site/PageServer?pagename=walk_homepage&autologin=true
Greater Illinois Chapter unveils Impact Report - The Alzheimer's Association, Greater Illinois Chapter FY 13 Impact Report is now available. The report is an important look at our progress over the past fiscal year. Compelling community-based programming, the signature fundraiser Walk to End Alzheimer's, diversity outreach and advocacy and public policy achievements are only a few ways the Greater Illinois Chapter is making a significant difference in the lives of those affected by Alzheimer's 12/04/2013
http://www.alzheimers-illinois.org/enewsletter/weekly/december2013/dec4/impact_report.pdf
« First | ‹ Previous |
See all Resources